Pharmatest Services is a preclinical CRO specialized in clinically predictive efficacy services. Our focus is in the fields of cancer and skeletal diseases ranging from in vitro cell culture assays, ex vivo bone analysis services to in vivo models. Our company was founded over 20 years ago and has extensive know-how in our fields of expertise. Pharmatest also offers customized model development for our customers.
Our immunotherapy drug development services include syngeneic models for breast, bladder, lung, colon and renal cancer, and multiple myeloma. These models can be conducted in orthotopic or metastatic setting - modelling bone metastases is our key expertise. The major advantage of these models is proper tissue microenvironment that is known to affect tumour properties and drug resistance. We have special expertise in testing various radiopharmaceuticals including alpha-emitters.
We are scientifically driven, and our mission is to reduce the amount of drug candidates failing in clinical trials.